AstraZeneca AZN reported its Q2 earnings results on Friday, July 29, 2022 at 08:00 AM.
Here's what investors need to know about the announcement.
Earnings
AstraZeneca beat estimated earnings by 11.69%, reporting an EPS of $0.86 versus an estimate of $0.77.
Revenue was up $2.55 billion from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.12 which was followed by a 1.22% drop in the share price the next day.
Here's a look at AstraZeneca's past performance:
Quarter | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 |
---|---|---|---|---|
EPS Estimate | 0.83 | 0.73 | 0.62 | 0.43 |
EPS Actual | 0.95 | 0.84 | 0.54 | 0.45 |
Revenue Estimate | 10.99B | 10.88B | 9.87B | 7.36B |
Revenue Actual | 11.39B | 12.01B | 9.87B | 8.22B |
To track all earnings releases for AstraZeneca visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.